LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio

---
LumaCina Appoints Gary Bird as CEO to Accelerate Growth and Expand Global Sterile Injectables Portfolio
Vote:
0 0
Previous GEM and Senhwa Biosciences have formally executed a Share Purchase Agreement for up to NT$500 million
Next CloudMile and Tookitaki Sign MoU to Strengthen AI-Driven Financial Crime Prevention in Malaysia

Related News

Bridgewest Perth Pharma to commercialize Sterile Injectable drugs under LumaCina business unit

Bridgewest Group launches NovaCina, new sterile injectable CDMO

DeTect to Deliver MERLIN™ True3D™ Bird Detection Radar to Hanseo University's Flight Education Center in South Korea

TricorBraun ANZ Appoints Louise Baker as Managing Director

Simpro names Gary Specter as CEO to lead new era of growth

THE FARRER PARK COMPANY APPOINTS NEW GROUP CHIEF OPERATING OFFICER AND ACTING GROUP CHIEF EXECUTIVE OFFICER

menu
menu